InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Patenting personalised medicine: Up close and personal

Patrick Wingrove, London

European in-house IP counsel tell Patrick Wingrove about the prospects and problems of individual treatments, particularly as AI plays a bigger role in making them

Personalised therapies are gaining great attention in the medical sphere but are raising big intellectual property challenges for drug manufacturers, according to in-house counsel.

Technology has reached a point where pharmaceutical companies can more accurately map out the genetics of...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null

null null null


July /August 2019

AI and IP: the view from above

Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable

Most read articles